Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts. It is a principal teaching affiliate of Harvard Medical School, and a founding member of Dana–Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.

Wikipedia
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Breast cancer is the most common type of cancer among women in the U.S., other than skin cancer. It often begins in lobules or ducts of the breast tissue; it can spread when the cancer cells get into the blood or lymph system. Every year in the United States, one […] The post Pregnancy and Breast Cancer: What You Need to Know appeared first on Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Addiction to drugs and other substances, including tobacco, can have far-reaching medical consequences, including cardiovascular disease, stroke, and cancer. According to the American Cancer Society, addiction accounts for approximately 30 percent of all cancer deaths, including about 80 percent of all lung cancer deaths. But is there a link between […] The post Illegal Drug Use and Cancer: What Y...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Common infections, such as those that cause the common cold, do not cause cancer or make cancer more likely to occur. However, infections with specific types of viruses, bacteria, or parasites can increase an individual's risk for certain kinds of cancer. The post Infections and Cancer: What You Should Know appeared first on Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Brain tumors are graded on a scale of 1 to 4, based on how malignant, or cancerous, they are, in an effort to anticipate the tumor's likely growth rate. A grade of 1 is the least malignant, and is considered low-grade, while 4 is the most malignant and considered high-grade. The post What Makes a Brain Tumor High-Grade or Low-Grade? appeared first on Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Gene therapy is a way of treating or preventing disease by altering the genetic instructions within an individual’s cells. Genes are responsible for virtually every aspect of cell life: they hold the code for proteins that enable cells to grow, function, and divide. When a gene is defective, it can […] The post How is Gene Therapy Being Used to Treat Cancer? appeared first on Dana-Farber Cancer In...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
YouTube Video
  • Dr. Allison O’Neill, Director of the Pediatric Liver Tumor Program at Dana-Farber Cancer Institute, cares for children with all types of liver tumors while focusing her clinical and research expertise on hepatoblastoma and hepatocellular carcinoma. Dr. O’Neill explains how, at Dana-Farber/Boston Children’s, a multidisciplinary team of experts work together to provide specialized and individualized...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • CAR T-cell therapy is a form of immunotherapy that uses specially modified T cells – part of the body’s defense system against disease – to attack cancer. In clinical trials, this therapy has proven strikingly successful in patients with certain forms of blood cancer. It has been approved by the […] The post How Treatment Works for CAR T-Cell Therapy Patients appeared first on Dana-Farber Cancer I...

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

By signing up, you agree to the Terms of Service and Privacy Policy.

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in

By signing up, you agree to the Terms of Service and Privacy Policy.